Farmacias Benavides, S.A.B. de C.V.
FBNVF
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 3.91M | 3.41M | 3.31M | 2.85M | 5.15M |
| Total Depreciation and Amortization | 17.54M | 13.63M | 13.09M | 14.45M | 14.93M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.23M | 5.47M | -32.07M | 7.05M | 3.60M |
| Change in Net Operating Assets | -10.36M | -9.35M | 18.53M | 2.41M | -12.91M |
| Cash from Operations | 21.33M | 13.17M | 2.87M | 26.76M | 10.77M |
| Capital Expenditure | -808.70K | -3.62M | -2.50M | -4.40M | -6.98M |
| Sale of Property, Plant, and Equipment | 141.50K | 170.30K | 278.40K | 138.50K | 473.30K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 55.90K | 103.90K | -601.90K | 113.50K | 599.00K |
| Cash from Investing | -611.30K | -3.35M | -2.82M | -4.15M | -5.91M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -339.02M | -221.56M | 313.69M | -231.58M | -161.38M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -112.24M | -76.80M | -72.01M | -67.30M | -63.57M |
| Cash from Financing | -26.19M | -17.58M | 13.79M | -17.53M | -12.72M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.48M | -7.76M | 13.84M | 5.08M | -7.86M |
